Prof. Dr. Markus Löffler Universität Leipzig Institut für Medizinische Informatik, Statistik und Epidemiologie Härtelstraße 16-18 04107 Leipzig
Expertise: Not specified
Tools: Not specified

Project roles
Pal
- LIFE HNC - Head and Neck Cancer Group
- MMML-MYC-SYS
- LIFE Adult
- GLA - German Lymphoma Alliance
- MMML - Molecular mechanisms in malignant lymphoma
- MMML Demonstrators - Molecular Mechanisms in Malignant Lymphomas - Demonstrators of Personalized Medicine
- HaematoSys - Systems biology of haematopoiesis and haematopoietic neoplasia
- SMITH - Smart Medical Information Technology for Healthcare
- LHA - Leipzig Health Atlas

This person has not yet tagged anything.
Genetical Statistics and Systems Biology (Institute for Medical Informatics, Statistics and Epidemiology (IMISE)) ; MMML Demonstrators - Molecular Mechanisms in Malignant Lymphomas - Demonstrators of Personalized Medicine (Institute for Medical Informatics, Statistics and Epidemiology (IMISE)) ; LIFE HNC - Head and Neck Cancer Group (Institute for Medical Informatics, Statistics and Epidemiology (IMISE)) ; MMML-MYC-SYS (Institute for Medical Informatics, Statistics and Epidemiology (IMISE)) ; LIFE Adult (Institute for Medical Informatics, Statistics and Epidemiology (IMISE)) ; GLA - German Lymphoma Alliance (Institute for Medical Informatics, Statistics and Epidemiology (IMISE)) ; MMML - Molecular mechanisms in malignant lymphoma (Institute for Medical Informatics, Statistics and Epidemiology (IMISE)) ; SepNet - German Competence Network Sepsis (Institute for Medical Informatics, Statistics and Epidemiology (IMISE)) ; HaematoSys - Systems biology of haematopoiesis and haematopoietic neoplasia (Institute for Medical Informatics, Statistics and Epidemiology (IMISE)) ; SMITH - Smart Medical Information Technology for Healthcare (Institute for Medical Informatics, Statistics and Epidemiology (IMISE)) ; LHA - Leipzig Health Atlas (Institute for Medical Informatics, Statistics and Epidemiology (IMISE)) ; POLAR - Polypharmacy, Drug Interactions, Risks (Institute for Medical Informatics, Statistics and Epidemiology (IMISE)) ; SMITH - Smart Medical Information Technology for Healthcare (University of Leipzig) ; COVID-19 Leipzig (Institute for Medical Informatics, Statistics and Epidemiology (IMISE))
Related items
- Projects (15)
- Institutions (2)
- Investigations (1)
- Studies (1)
- Resources (2)
- Publications (185)
- Data files (20+2)
- Documents (22)
- Programmes (3)
This project serves as a container for all COVID-19 related assets, developed at the University of Leipzig and its partners.
Organisms: Homo sapiens, Severe acute respiratory syndrome coronavirus 2
Human Diseases: COVID-19
Programme: MII - Medical Informatics Initiative
Public web page: https://www.smith.care/
Start date: 1st Jan 2018
Organisms: Homo sapiens
The Leipzig Health Atlas (LHA) is an alliance of medical ontologists, medical systems biologists and clinical trials groups to design and implement a multi-functional and quality-assured atlas. It provides models, data and metadata on specific use cases from medical research fields in which our team has scientific and clinical expertise.
Programme: This Project is not associated with a Programme
Public web page: https://www.health-atlas.de
Start date: 1st Apr 2016
End date: 28th Feb 2021
Organisms: Homo sapiens
During 2003 and 2011 the german cancer aid funded the molecular mechanisms in malignant lymphomas (MMML) project. It is based on strongly interacting networks of reference pathologists, lymphoma scientists, bioinformaticians and clinical trial groups. Within the project about 1000 lymphoma samples and controls were characterized by gene expression and copy number arrays. The datasets were supplemented by extensive histopathological and clinical descriptions of the lymphoma cases. The aim of the ...
Programme: This Project is not associated with a Programme
Public web page: Not specified
Organisms: Not specified
Human Diseases: non-Hodgkin lymphoma
MMML-MYC-SYS is a interdisciplinary consortium where partners from clinical haemaoncological study groups, pathologists, geneticicts, cell biologists as well as mathematicians, statisticians and bioinformaticists have allied. The goal is to investigate the process of development of B-cell lymphoma under special consideration of mutation of MYC. MYC is known to support the development and growth of tumors. This consortium collected and evaluated comprehensive molecular-genetic data for this purpose. ...
Programme: This Project is not associated with a Programme
Public web page: http://www.mmmlmycsys.de/
Start date: 1st Jan 2013
Organisms: Not specified
Human Diseases: non-Hodgkin lymphoma
The joint project "MMML Demonstrators" deals with improvements in the diagnosis and therapy of lymphoma and consists of seven subprojects. In lymphoma, the so-called diffuse large cell B-cell lymphomas (DLBCL) are responsible for the highest number of deaths. Although the disease is curable in principle, approximately one third of patients still die. However, the expression of certain genes in tumor cells and surrounding tissues can be used to diagnose certain subgroups of these tumors and, in ...
Programme: This Project is not associated with a Programme
Public web page: https://www.sys-med.de/de/demonstratoren/mmml-demonstrators/
Start date: 1st Jan 2015
End date: 31st Dec 2018
Organisms: Not specified
Human Diseases: diffuse large B-cell lymphoma
Goal of the Leipzig Research Center for Civilization Diseases (LIFE) is the investigation of civilization diseases like depression, diabetes, allergies or cardiovascular diseases. For this purpose we collect as much data as possible regarding health and living conditions of the population in Leipzig and provide these data for scientists of the University of Leipzig and other research institutions.
As an interdisciplinary network of scientists, the SepNet study group deals with the topics of severe sepsis and septic shock. The aim of the network is to create the prerequisites for better clinical and experimental research into sepsis and thus to develop efficient treatment approaches.
Programme: Epidemiology
Public web page: https://www.sepsis-stiftung.eu/sepnet/
Start date: 1st Jan 2003
Organisms: Homo sapiens
Human Diseases: disease by infectious agent
The aim of the Head and Neck Group within the Leipzig Research Center for Civilization Diseases (LIFE) is to facilitate improvements in the treatment and care of head and neck cancer patients through insights from molecular studies.
The Head and Neck Group within the Leipzig Research Center for Civilization Diseases (LIFE) investigates the molecular mechanisms and the diagnostic and prognostic factors of head and neck cancer. For this purpose, we collected phenotypic information from about 300 ...
Programme: This Project is not associated with a Programme
Public web page: http://life.uni-leipzig.de/
Start date: 1st Jan 2012
End date: 31st Dec 2012
Organisms: Homo sapiens
Human Diseases: head and neck cancer
The group is interested in omic-level studies including the genome, methylome, transcriptome, and metabolome of the general population as well as of various diseases including cardiovascular diseases, pneumonia, sepsis, obesity, and brain cancers. Additionally, we aim at transfering results of biomathematical model simulations into clinical practice e.g. by haematopoietic growth-factor opimization during cytotoxic chemotherapy and optimization of EPO applications in chronic kidney disease.
The ...
Programme: This Project is not associated with a Programme
Public web page: http://www.imise.uni-leipzig.de/en/Groups/GenStat/
Start date: 1st Jan 2013
Organisms: Homo sapiens
Severe sepsis and septic shock have a high mortality. Research has concentrated on adjunctive sepsis therapies; the role of supportive measures is comparatively unclear. In Europe the use of colloids is widespread, but there is no evidence on the role of either crystalloid or colloid volume therapy in sepsis. Recently, a higher incidence of kidney failure in sepsis was reported after administration of colloids.
Snapshots: No snapshots
Baseline Data and Endpoints for VISEP
Submitter: René Hänsel
Investigation: Efficacy of Volume Substitution and Insulin The...
Resources: VISEP metadata, VISEP trial data
Study type: Not specified
Snapshots: No snapshots
The role of intensive insulin therapy in patients with severe sepsis is uncertain. Fluid resuscitation improves survival among patients with septic shock, but evidence is lacking to support the choice of either crystalloids or colloids. We compared intensive insulin therapy with conventional insulin therapy and HES with Ringer’s lactate.
Submitter: René Hänsel
Resource type: Experimental Assay Type
Technology type: Technology Type
Investigation: Efficacy of Volume Substitution and Insulin The...
Study: VISEP
Human Diseases: disease by infectious agent
SOPs: No SOPs
Data files: VISEP Endpoint, VISEP Endpoint-ODM, VISEP Endpoint-SPSS, VISEP V-PAT, VISEP V-PAT-ODM, VISEP V-PAT-SPSS, VISEP V-VERL-join, VISEP V-VERL-join-ODM, VISEP V-VERL-join-SPSS, VISEP haemo_join, VISEP haemo_join-ODM, VISEP haemo_join-SPSS
Snapshots: No snapshots
The role of intensive insulin therapy in patients with severe sepsis is uncertain. Fluid resuscitation improves survival among patients with septic shock, but evidence is lacking to support the choice of either crystalloids or colloids. We compared intensive insulin therapy with conventional insulin therapy and HES with Ringer’s lactate.
Submitter: René Hänsel
Resource type: Experimental Assay Type
Technology type: Technology Type
Investigation: Efficacy of Volume Substitution and Insulin The...
Study: VISEP
Human Diseases: disease by infectious agent
SOPs: No SOPs
Data files: VISEP Endpoint Metadata, VISEP Endpoint Metadata-ODM, VISEP V-PAT Metadata, VISEP V-PAT Metadata-ODM, VISEP V-VERL-join Metadata, VISEP V-VERL-join Metadata-ODM, VISEP haemo_join Metadata, VISEP haemo_join Metadata-ODM
Snapshots: No snapshots
Abstract (Expand)
Authors: M. Schmidt, L. Hopp, A. Arakelyan, H. Kirsten, C. Engel, K. Wirkner, K. Krohn, R. Burkhardt, J. Thiery, M. Loeffler, H. Loeffler-Wirth, H. Binder
Date Published: 11th Mar 2021
Publication Type: Journal article
PubMed ID: 33693414
Citation: Front Big Data. 2020 Oct 30;3:548873. doi: 10.3389/fdata.2020.548873. eCollection 2020.
Abstract (Expand)
Authors: Maciej Rosolowski, Volker Oberle, Peter Ahnert, Petra Creutz, Martin Witzenrath, Michael Kiehntopf, Markus Loeffler, Norbert Suttorp, Markus Scholz
Date Published: 1st Dec 2020
Publication Type: Journal article
Abstract (Expand)
Authors: Katja Hoffmann, Katja Cazemier, Christoph Baldow, Silvio Schuster, Yuri Kheifetz, Sibylle Schirm, Matthias Horn, Thomas Ernst, Constanze Volgmann, Christian Thiede, Andreas Hochhaus, Martin Bornhäuser, Meinolf Suttorp, Markus Scholz, Ingmar Glauche, Markus Loeffler, Ingo Roeder
Date Published: 1st Dec 2020
Publication Type: Journal article
Abstract (Expand)
Authors: F. Beyer, R. Zhang, M. Scholz, K. Wirkner, M. Loeffler, M. Stumvoll, A. Villringer, A. V. Witte
Date Published: 25th Oct 2020
Publication Type: Journal article
PubMed ID: 33100325
Citation: Int J Obes (Lond). 2020 Oct 25. pii: 10.1038/s41366-020-00702-4. doi: 10.1038/s41366-020-00702-4.
Abstract (Expand)
Authors: E. Hofer, G. V. Roshchupkin, H. H. H. Adams, M. J. Knol, H. Lin, S. Li, H. Zare, S. Ahmad, N. J. Armstrong, C. L. Satizabal, M. Bernard, J. C. Bis, N. A. Gillespie, M. Luciano, A. Mishra, M. Scholz, A. Teumer, R. Xia, X. Jian, T. H. Mosley, Y. Saba, L. Pirpamer, S. Seiler, J. T. Becker, O. Carmichael, J. I. Rotter, B. M. Psaty, O. L. Lopez, N. Amin, S. J. van der Lee, Q. Yang, J. J. Himali, P. Maillard, A. S. Beiser, C. DeCarli, S. Karama, L. Lewis, M. Harris, M. E. Bastin, I. J. Deary, A. Veronica Witte, F. Beyer, M. Loeffler, K. A. Mather, P. R. Schofield, A. Thalamuthu, J. B. Kwok, M. J. Wright, D. Ames, J. Trollor, J. Jiang, H. Brodaty, W. Wen, M. W. Vernooij, A. Hofman, A. G. Uitterlinden, W. J. Niessen, K. Wittfeld, R. Bulow, U. Volker, Z. Pausova, G. Bruce Pike, S. Maingault, F. Crivello, C. Tzourio, P. Amouyel, B. Mazoyer, M. C. Neale, C. E. Franz, M. J. Lyons, M. S. Panizzon, O. A. Andreassen, A. M. Dale, M. Logue, K. L. Grasby, N. Jahanshad, J. N. Painter, L. Colodro-Conde, J. Bralten, D. P. Hibar, P. A. Lind, F. Pizzagalli, J. L. Stein, P. M. Thompson, S. E. Medland, P. S. Sachdev, W. S. Kremen, J. M. Wardlaw, A. Villringer, C. M. van Duijn, H. J. Grabe, W. T. Jr Longstreth, M. Fornage, T. Paus, S. Debette, M. Arfan Ikram, H. Schmidt, R. Schmidt, S. Seshadri
Date Published: 22nd Sep 2020
Publication Type: Journal article
PubMed ID: 32963231
Citation: Nat Commun. 2020 Sep 22;11(1):4796. doi: 10.1038/s41467-020-18367-y.
Abstract (Expand)
Authors: Anke Toenjes, Annett Hoffmann, Susan Kralisch, Abdul Rashid Qureshi, Nora Klöting, Markus Scholz, Dorit Schleinitz, Anette Bachmann, Juergen Kratzsch, Marcin Nowicki, Sabine Paeschke, Kerstin Wirkner, Cornelia Enzenbach, Ronny Baber, Joachim Beige, Matthias Anders, Ingolf Bast, Matthias Blüher, Peter Kovacs, Markus Löffler, Ming-Zhi Zhang, Raymond C. Harris, Peter Stenvinkel, Michael Stumvoll, Mathias Fasshauer, Thomas Ebert
Date Published: 1st Sep 2020
Publication Type: Journal article
PubMed ID: 32508317
DOI: 10.1530/EJE-20-0087
Citation: European Journal of Endocrinology 183(3):233-244
Abstract (Expand)
Authors: Michael Rode, Andrej Teren, Kerstin Wirkner, Katrin Horn, Holger Kirsten, Markus Loeffler, Markus Scholz, Janne Pott
Date Published: 13th Aug 2020
Publication Type: Journal article
Human Diseases: arteriosclerosis, arteriosclerotic cardiovascular disease
DOI: 10.1371/journal.pone.0237237
Citation: PLoS ONE 15(8):e0237237
Abstract (Expand)
Authors: Neda Baniasadi, Franziska G. Rauscher, Dian Li, Mengyu Wang, Eun Young Choi, Hui Wang, Thomas Peschel, Kerstin Wirkner, Toralf Kirsten, Joachim Thiery, Christoph Engel, Markus Loeffler, Tobias Elze
Date Published: 3rd Aug 2020
Publication Type: Journal article
DOI: 10.1167/tvst.9.9.23
Citation: Trans. Vis. Sci. Tech. 9(9):23
Abstract (Expand)
Authors: Jean Shin, Shaojie Ma, Edith Hofer, Yash Patel, Daniel E. Vosberg, Steven Tilley, Gennady V. Roshchupkin, André M. M. Sousa, Xueqiu Jian, Rebecca Gottesman, Thomas H. Mosley, Myriam Fornage, Yasaman Saba, Lukas Pirpamer, Reinhold Schmidt, Helena Schmidt, Amaia Carrion-Castillo, Fabrice Crivello, Bernard Mazoyer, Joshua C. Bis, Shuo Li, Qiong Yang, Michelle Luciano, Sherif Karama, Lindsay Lewis, Mark E. Bastin, Mathew A. Harris, Joanna M. Wardlaw, Ian E. Deary, Markus Scholz, Markus Loeffler, A. Veronica Witte, Frauke Beyer, Arno Villringer, Nicola J. Armstrong, Karen A. Mather, David Ames, Jiyang Jiang, John B. Kwok, Peter R. Schofield, Anbupalam Thalamuthu, Julian N. Trollor, Margaret J. Wright, Henry Brodaty, Wei Wen, Perminder S. Sachdev, Natalie Terzikhan, Tavia E. Evans, Hieab H. H. H. Adams, M. Arfan Ikram, Stefan Frenzel, Sandra van der Auwera-Palitschka, Katharina Wittfeld, Robin Bülow, Hans Jörgen Grabe, Christophe Tzourio, Aniket Mishra, Sophie Maingault, Stephanie Debette, Nathan A. Gillespie, Carol E. Franz, William S. Kremen, Linda Ding, Neda Jahanshad, Nenad Sestan, Zdenka Pausova, Sudha Seshadri, Tomas Paus
Date Published: 1st Jun 2020
Publication Type: Journal article
Abstract (Expand)
Authors: J. Pott, F. Beutner, K. Horn, H. Kirsten, K. Olischer, K. Wirkner, M. Loeffler, M. Scholz
Date Published: 30th May 2020
Publication Type: Journal article
Human Diseases: cardiovascular system disease, atherosclerosis
PubMed ID: 32469969
Citation: PLoS One. 2020 May 29;15(5):e0233728. doi: 10.1371/journal.pone.0233728. eCollection 2020.
Investigations: Efficacy of Volume Substitution and Insulin The...
Studies: VISEP
Resources: VISEP trial data
Investigations: Efficacy of Volume Substitution and Insulin The...
Studies: VISEP
Resources: VISEP trial data
Investigations: Efficacy of Volume Substitution and Insulin The...
Studies: VISEP
Resources: VISEP trial data
Investigations: Efficacy of Volume Substitution and Insulin The...
Studies: VISEP
Resources: VISEP trial data
Investigations: Efficacy of Volume Substitution and Insulin The...
Studies: VISEP
Resources: VISEP trial data
Investigations: Efficacy of Volume Substitution and Insulin The...
Studies: VISEP
Resources: VISEP trial data
Investigations: Efficacy of Volume Substitution and Insulin The...
Studies: VISEP
Resources: VISEP trial data
Investigations: Efficacy of Volume Substitution and Insulin The...
Studies: VISEP
Resources: VISEP trial data
Investigations: Efficacy of Volume Substitution and Insulin The...
Studies: VISEP
Resources: VISEP trial data
Investigations: Efficacy of Volume Substitution and Insulin The...
Studies: VISEP
Resources: VISEP trial data
Summary of the current COVID-19 pandemic development in Leipzig and Saxony. This work was done as part of the NFDI4Health Task Force COVID-19 (nfdi4health.de). We gratefully acknowledge the financial support of the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) – Project Number 451265285.
Creators: Holger Kirsten, Torsten Thalheim, Markus Scholz, Markus Löffler
Submitter: René Hänsel
Investigations: No Investigations
Studies: No Studies
Resources: No Resources
Summary of the current COVID-19 pandemic development in Leipzig and Saxony. This work was done as part of the NFDI4Health Task Force COVID-19 (nfdi4health.de). We gratefully acknowledge the financial support of the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) – Project Number 451265285.
Creators: Holger Kirsten, Torsten Thalheim, Markus Scholz, Markus Löffler
Submitter: René Hänsel
Investigations: No Investigations
Studies: No Studies
Resources: No Resources
Summary of the current COVID-19 pandemic development in Leipzig and Saxony. This work was done as part of the NFDI4Health Task Force COVID-19 (nfdi4health.de). We gratefully acknowledge the financial support of the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) – Project Number 451265285.
Creators: Holger Kirsten, Torsten Thalheim, Markus Scholz, Markus Löffler, Peter Ahnert, Marcin Bodych, Karolin Bucksch, Friedemann Horn, Matthias Horn, Radosław Idzikowski, Yuri Kheifetz, Tyll Krüger
Submitter: Christoph Beger
Investigations: No Investigations
Studies: No Studies
Resources: No Resources
Summary of the current COVID-19 pandemic development in Leipzig and Saxony. This work was done as part of the NFDI4Health Task Force COVID-19 (nfdi4health.de). We gratefully acknowledge the financial support of the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) – Project Number 451265285.
Creators: Torsten Thalheim, Markus Scholz, Markus Löffler, Holger Kirsten, Peter Ahnert, Karolin Bucksch, Anne Dietrich, Dirk Hasenclever, Matthias Horn, Yuri Kheifetz, Tyll Krüger, Sibylle Schirm
Submitter: René Hänsel
Investigations: No Investigations
Studies: No Studies
Resources: No Resources
Summary of the current COVID-19 pandemic development in Leipzig and Saxony. This work was done as part of the NFDI4Health Task Force COVID-19 (nfdi4health.de). We gratefully acknowledge the financial support of the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) – Project Number 451265285.
Creators: Torsten Thalheim, Markus Scholz, Markus Löffler, Holger Kirsten, Peter Ahnert, Karolin Bucksch, Anne Dietrich, Dirk Hasenclever, Matthias Horn, Yuri Kheifetz, Tyll Krüger, Sibylle Schirm
Submitter: Christoph Beger
Investigations: No Investigations
Studies: No Studies
Resources: No Resources
Summary of the current COVID-19 pandemic development in Leipzig and Saxony. This work was done as part of the NFDI4Health Task Force COVID-19 (nfdi4health.de). We gratefully acknowledge the financial support of the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) – Project Number 451265285.
Creators: Torsten Thalheim, Holger Kirsten, Markus Scholz, Markus Löffler, Peter Ahnert, Anne Dietrich, Dirk Hasenclever, Matthias Horn, Yuri Kheifetz, Tyll Krüger, Sibylle Schirm
Submitter: Christoph Beger
Investigations: No Investigations
Studies: No Studies
Resources: No Resources
Summary of the current COVID-19 pandemic development in Leipzig and Saxony. This work was done as part of the NFDI4Health Task Force COVID-19 (nfdi4health.de). We gratefully acknowledge the financial support of the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) – Project Number 451265285.
Creators: Holger Kirsten, Markus Scholz, Markus Löffler, Peter Ahnert, Karolin Bucksch, Anne Dietrich, Dirk Hasenclever, Matthias Horn, Yuri Kheifetz, Tyll Krüger, Sibylle Schirm
Submitter: Christoph Beger
Investigations: No Investigations
Studies: No Studies
Resources: No Resources
Summary of the current COVID-19 pandemic development in Leipzig and Saxony. This work was done as part of the NFDI4Health Task Force COVID-19 (nfdi4health.de). We gratefully acknowledge the financial support of the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) – Project Number 451265285.
Creators: Holger Kirsten, Markus Löffler, Markus Scholz, Peter Ahnert, Anne Dietrich, Dirk Hasenclever, Matthias Horn, Yuri Kheifetz, Tyll Krüger, Sibylle Schirm
Submitter: Christoph Beger
Investigations: No Investigations
Studies: No Studies
Resources: No Resources
Summary of the current COVID-19 pandemic development in Leipzig and Saxony. This work was done as part of the NFDI4Health Task Force COVID-19 (nfdi4health.de). We gratefully acknowledge the financial support of the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) – Project Number 451265285.
Creators: Holger Kirsten, Markus Löffler, Markus Scholz, Peter Ahnert, Dirk Hasenclever, Matthias Horn, Yuri Kheifetz, Sibylle Schirm
Submitter: Christoph Beger
Investigations: No Investigations
Studies: No Studies
Resources: No Resources
Summary of the current COVID-19 pandemic development in Leipzig and Saxony. This work was done as part of the NFDI4Health Task Force COVID-19 (nfdi4health.de). We gratefully acknowledge the financial support of the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) – Project Number 451265285.
Creators: Holger Kirsten, Markus Löffler, Markus Scholz, Peter Ahnert, Dirk Hasenclever, Matthias Horn, Yuri Kheifetz, Sibylle Schirm
Submitter: Christoph Beger
Investigations: No Investigations
Studies: No Studies
Resources: No Resources
The medical informatics initiative was created to close the gap between research and healthcare. All of Germany’s university hospitals have joined forces with research institutions, businesses, health insurers, and patient advocacy groups to create a framework that harnesses research findings to the direct benefit of patients. The German Federal Ministry of Education and Research (BMBF) is investing around 160 million euros in the programme through 2021. The digitisation of medicine is creating ...
Projects: SMITH - Smart Medical Information Technology for Healthcare, POLAR - Polypharmacy, Drug Interactions, Risks
Projects: LIFE - Leipzig Research Center for Civilization Diseases, LIFE Heart, SepNet - German Competence Network Sepsis, GC-HNPCC - German Consortium for Hereditary Non-Polyposis Colorectal Cancer, COVID-19 Leipzig, LIFE Adult, GC-HBOC - German Consortium for Hereditary Breast and Ovarian Cancer
Web page: Not specified
Projects: HaematoSys - Systems biology of haematopoiesis and haematopoietic neoplasia, GLA - German Lymphoma Alliance
Web page: Not specified